Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Intrexon reported $-20076000 in EBITDA for its fiscal quarter ending in December of 2022.

Ebitda Change
Agenus AGEN:US USD -52185000 3.55M
Alaunos Therapeutics Inc ZIOP:US USD -8976000 1.15M
Amgen AMGN:US USD 3B 42M
Arrowhead Research ARWR:US USD 50.84M 90.27M
AstraZeneca AZN:LN USD 4.28B 965M
Bluebird Bio BLUE:US USD -83411000 8.1M
Bristol-Myers Squibb BMY:US USD 5.43B 772M
Gilead Sciences GILD:US USD 2.24B 456M
GlaxoSmithKline GSK:LN GBP 2.56B 960M
Immunogen IMGN:US USD -41945000 17.19M
Incyte Corp INCY:US USD 48.82M 62.76M
MacroGenics MGNX:US USD -35443000 50.66M
MannKind MNKD:US USD -3986000 3.71M
Novartis NOVN:VX USD 4.72B 217M
Peregrine Pharmaceuticals PPHM:US USD 4.64M 5.5M
Roche Holding ROG:VX CHF 10.43B 3B
Sangamo BioSciences SGMO:US USD 80.09M 132.14M
Thermo Fisher Scientific TMO:US USD 2.56B 204M
Xencor XNCR:US USD -57120000 16.69M